We thus asked whether LC gene expression was affected by APOE haplotype in an ancestry-differentiated manner—and whether EA E4-E2 comparisons showed broader effects relative to AA E4-E2 comparisons, which would support an etiologically important role of APOE haplotype in LC vulnerability to AD pathology. This evidence concerns the gene APOE and Alzheimer disease.